Aura Biosciences, Inc.

NASDAQ:AURA

10.96 (USD) • At close November 7, 2024
Bedrijfsnaam Aura Biosciences, Inc.
Symbool AURA
Munteenheid USD
Prijs 10.96
Beurswaarde 543,682,998
Dividendpercentage 0%
52-weken bereik 6.63 - 12.378
Industrie Biotechnology
Sector Healthcare
CEO Dr. Elisabet de los Pinos Ph.D.
Website https://www.aurabiosciences.com

An error occurred while fetching data.

Over Aura Biosciences, Inc.

Aura Biosciences, Inc. operates as a biotechnology company that develops therapies to treat cancer. The company develops virus-like drug conjugates (VDC) technology platform for the treat tumors of high unmet need in ocular and urologic oncology. It develops AU-011, a VDC candidate for the treatment of primary choroidal melanoma. It

Vergelijkbare Aandelen

Tango Therapeutics, Inc. logo

Tango Therapeutics, Inc.

TNGX

2.83 USD

Geron Corporation logo

Geron Corporation

GERN

4.29 USD

Century Therapeutics, Inc. logo

Century Therapeutics, Inc.

IPSC

1.46 USD

Stoke Therapeutics, Inc. logo

Stoke Therapeutics, Inc.

STOK

13.27 USD

Caribou Biosciences, Inc. logo

Caribou Biosciences, Inc.

CRBU

2.78 USD

PetIQ, Inc. logo

PetIQ, Inc.

PETQ

30.98 USD

ANI Pharmaceuticals, Inc. logo

ANI Pharmaceuticals, Inc.

ANIP

58.38 USD

GH Research PLC logo

GH Research PLC

GHRS

8.62 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)